Withdrawal Symptoms

Search with Google Search with Bing
Information
Disease name
Withdrawal Symptoms
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03557294 Completed Phase 4 Varenicline OTC Trial on Efficacy and Safety May 7, 2018 April 16, 2022
NCT02044757 Completed N/A The Potentially Addictive Properties of Soda: A Feasibility Study June 2013 August 2014
NCT02391571 Completed Phase 3 A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects February 2015 March 2015
NCT05485519 Recruiting Phase 3 Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs. April 21, 2022 May 2024
NCT05834478 Recruiting Phase 3 Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 February 20, 2024 December 2026
NCT04850664 Unknown status Phase 2 Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder March 26, 2021 December 31, 2022
NCT05264428 Unknown status N/A The Effect of Honey on Lessening the Withdrawal Symptoms September 3, 2021 June 30, 2023